Semaglutide has emerged as a novel treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to release more insulin and suppressing glucagon https://kalemfvj026752.blue-blogs.com/43197124/understanding-semaglutide-a-comprehensive-guide